Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2012 / Cilt: 58 - Sayı: 3

Osteoporosis risk assessment

Osteoporoz riskinin değerlendirilmesi

Pages
212–219
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Turk J Phys Med Re hab 2012;58:212-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ob jec ti ve: The aim of this study was to determine which patients have priority for Bone Mineral Density (BMD) measurement by using osteoporosis risk indices in order to reduce diagnostic costs.
📊
Key Findings & Data:Metarials and Methods: BMD at the lumbar spine (L1-L4) and the femur neck was measured using Dual Energy X-Ray absorptiometry in 537 postmenopausal women aged 45 years or older.
💡
Conclusion & Impact:Turk J Phys Med Re hab 2012;58:212-19.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Ob jec ti ve: The aim of this study was to determine which patients have priority for Bone Mineral Density (BMD) measurement by using osteoporosis risk indices in order to reduce diagnostic costs. Metarials and Methods: BMD at the lumbar spine (L1-L4) and the femur neck was measured using Dual Energy X-Ray absorptiometry in 537 postmenopausal women aged 45 years or older. Risk indices like Osteoporosis Screening Tool (OST), Simple Calculated Osteoporosis Risk Estimation (SCORE), Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Index of Risk (OSIRIS) and the WHO Fracture Risk Assessment Tool (FRAX) scores were calculated. Sensitivity, selectivity, positive and negative predictive values of the indexes was investigated to detect patients with low BMD. Results: Osteoporosis was observed in34,3% of the subjects. Osteoporosis rate was found to be high in high-risk groups of all indexes. The most effective indices were observed to be OST, SCORE and FRAX-H, in terms of sensitivity, selectivity, positive and negative predicting value. However, in the lumbar region, ratio of patients that can be missed using indexes was not found low enough. Conclusion: In this study, the most effective indices were observed to be OST, SCORE and FRAX-H. The rate of overlooked patients was not low enough in the lumbar area. We believe that, it would be useful to use screening tests for femur osteoporosis. Turk J Phys Med Re hab 2012;58:212-19.

Özet

Amaç: Bu çalışmanın amacı maliyetleri en aza indirmek için osteoporoz risk indekslerini kullanarak kemik mineral yoğunluğu (KMY) ölçümünde hangi hastalara öncelik verileceğini belirlemektir. Gereç ve Yöntem: Çalışmaya 45 yaş ve üzeri 537 postmenopozal kadın alındı. L1-L4 vertebra ve femur boynu KMY’leri Dual Enerji X-Ray Absorpsiyometri yöntemiyle ölçüldü. Osteoporoz Tarama Aracı (Osteoporosis Screening Tool-OST), Basit Hesaplanan Osteoporoz Risk Tahmini (Simple Calculated Osteoporosis Risk Estimation-SCORE), Osteoporoz Risk Değerlendirme Aracı (Osteoporosis Risk Assessment Instrument-ORAI), Osteoporoz Risk İndeksi (Osteoporosis Index of Risk- OSIRIS) indeksleri ve Dünya Sağlık Örgütü Kırık Riski Değerlendirme Aracı (WHO Fracture Risk Assessment Tool-FRAX) algoritması uygulandı. KMY’si düşük olguları ayırdetmede tahmin değeri en yüksek olan risk indekslerini saptamak amacıyla, indekslerin duyarlılık, seçicilik, pozitif ve negatif tahmin değerleri (PTD ve NTD) araştırıldı. Bulgular: Olguların %34,3’ünde osteoporoz saptandı. Tüm indekslerde, yüksek risk gruplarında osteoporoz oranı daha yüksekti. Bu çalışmada duyarlılık, seçicilik, PTD ve NTD yönünden en etkili indeksler OST, SCORE ve FRAX-H olarak izlendi. Ancak lomber bölgede, indeksler ile gözden kaçabilecek hasta oranı yeterince düşük bulunmadı. Sonuç: Lomber bölgede gözden kaçabilecek hasta oranını azaltabilmek için eşik değerlerin yeniden belirlenmesi gerekebilir. Bu yönde çalışmalar gereklidir. Ancak osteoporozda major morbidite ve mortalitenin kalça osteoporozu ve kırıklarına bağlı olduğu düşünülürse bu testlerin tarama testi olarak yararlı olacağı ileri sürülebilir. Türk Fiz Tıp Re hab Derg 2012;58:212-19

🔖

Cite This Article

İPEK, A., GAFUROĞLU, Ü., YILMAZ, Ö., BODUR, H. (2022). Osteoporosis risk assessment. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 58 - Sayı: 3, 212–219. https://ajindex.com/articles/628911

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lips P; International Osteoporosis Foundation (IOF) Committee of Scientific Advisors. Invest in your bones: quality of life. Why prevent the first fracture? International Osteoporosis Foundation (IOF). Nyon (Switzerland): 2003
  2. Bartl R, Frisch B. Kemik mineral yoğunluğu (KMY): Çok önemli bir tanısal parametre. içinde: Tan AA, editor. Osteoporoz teşhis korunma tedavi
  3. Baskı Ankara, Ortadoğu Reklam Tanıtım ve Yayıncılık A.Ş; 2006. s. 58-72
  4. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129
  5. Richy F, Gourlay M, Ross PD, Sen SS, Radican L, De Ceulaer F, et al. Validation and comparative evaluation of the osteoporosisselfassessment tool (OST) in a Caucasian population from Belgium. QJM 2004;97:39-46
  6. Caderette SM, Jaglal SB, Murray TM. Validation of the simple calculated osteoporosis risk estimation (SCORE) for patient selection for bone densitometry. Osteoporos Int 1999;10:85-90
  7. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 2000;162:1289-94
  8. Sedrine WB, Chevallier T, Zegels B, Kvasz A, Micheletti MC, Gelas B, et al. Development and assessment of the osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecol Endocrinol 2002;16:245-50
  9. Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX® and its applications to clinical practice. Bone 2009;44:734-43
  10. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. March 7-29, 2000: highlights of the conferance. South Med J 2001;94:569-73
  11. Johnel O. Advances in osteoporosis: better identification of risk factors can reduce morbidity and mortality. J Intern Med 1996;239:299-304
  12. Adami S, Giannini S, Giorgino R, Isaia G, Maggi S, Sinigaglia L, et al. The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 2003;14:198-207
  13. Reginster J-Y, Kung A, Koh L, et al. A simple chart for evaluating risk of osteoporosis in Asian women based on the osteoporosis self-assessment tool for Asians (OSTA). Osteoporos Int 2002;13:30
  14. Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, et al. A simple tool to identify